Web赛默飞Alfa aesar官网 赛默飞Acros试剂中国官网 Alfa aesar阿法埃莎中国代理商 WebDec 20, 2024 · An Open-Label, Dose-Escalation /Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies Status: Active Age: 18 years and over Gender: Male or Female Location: 11 locations Primary ID INCB 59872-101 Secondary IDs NCI-2016-00447 Clinicaltrials.gov ID NCT02712905 BREAST CANCER
A Study of INCB059872 in Relapsed or Refractory Ewing …
WebINCB059872(INCB-059872),CAS:1802909-49-4.INCB059872 (INCB-059872, INCB 59872) is a potent, selective, and orally active lysine-specific demethylase 1 (LSD1) inhibitor.Quality confirmed by NMR,HPLC & MS. Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists. WebFeb 18, 2016 · ID Number: INCB 59872-101. NCT Identifier: NCT02712905. NCT02712905, March 24, 2024. Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database. imbued enchantment
Targeting of epigenetic co-dependencies enhances anti-AML …
WebIn this review, we analyze those proteins and their inhibitors that have already reached the first stages of clinical trials in AML, namely the histone methyltransferase DOT1L, the demethylase LSD1, and the MLL-interacting protein menin. Keywords: acute myeloid leukemia, epigenetic modifications, methyltransferases, demethylases. WebApr 24, 2024 · The purpose of this study was to evaluate the safety and tolerability, and the pharmacokinetic and biologic activity of INCB059872 in participants with sickle cell disease. Study Overview Status Terminated Conditions Sickle Cell Disease Intervention / Treatment Drug: INCB059872 Study Type Interventional Enrollment (Actual) 12 Phase Phase 1 WebNov 5, 2024 · Methods: INCB 57643-103 (NCT04279847) is a phase 1, single-arm, open-label, two-part dose confirmation and expansion study evaluating INCB057643 in patients with measurable histologically or cytologically confirmed (World Health Organization criteria 2016), relapsed or refractory primary MF or secondary MF (post-polycythemia vera, post … list of jeff dunham dvd